Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis.
Eun Mi SongEun Hye OhSung Wook HwangSang Hyoung ParkDong-Hoon YangSeung Wook HongSeung-Jae MyungSuk-Kyun YangByong Duk YePublished in: Journal of gastroenterology and hepatology (2021)
Among Korean patients with SR-ASUC, the rates of treatment failure and colectomy at 3 months were not significantly different between the CSA and the IFX treatment groups.